Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca: A randomized double-blind clinical trial

Cornea

Volumn 32, Issue 10, 2013, Pages 1297-1304

  Sheppard, John D ^a,b   Singh, Ruhi ^c   McClellan, Andrew J ^d   Weikert, Mitchell P ^d   Scoper, Stephen V ^a,b   Joly, Thomas J ^a,b   Whitley, Walter O ^b   Kakkar, Ekta ^d   Pflugfelder, Stephen C ^c,d  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Virginia Eye Consultants   (United States)

^c CULLEN EYE INSTITUTE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Conjunctival impression cytology; Corneal topography indexes; Dry eye therapy; Gamma linolenic acid; Human leukocyte antigen DR; Ocular Surface Disease Index; Omega 3 fatty acids

Indexed keywords

GAMMA LINOLENIC ACID; HLA DR ANTIGEN; OMEGA 3 FATTY ACID; PLACEBO; DYE; EYE DROPS; FLUORESCEIN; GLYCOPROTEIN P 15095;

ADULT; ANOREXIA; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DENDRITIC CELL; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DYSGEUSIA; DYSPEPSIA; FACIAL EXPRESSION; FEMALE; HUMAN; IMPRESSION CYTOLOGY; INFECTION; KERATOCONJUNCTIVITIS SICCA; KERATOMETRY; LONG TERM CARE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PHYSICAL DISEASE BY BODY FUNCTION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCHIRMER TEST; SKIN BRUISING; SLIT LAMP; STAINING; TREATMENT DURATION; VISUAL ACUITY; VOMITING; AGED; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONJUNCTIVA; LACRIMAL FLUID; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD11C; CONJUNCTIVA; CORNEAL TOPOGRAPHY; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FLUORESCEIN; GAMMA-LINOLENIC ACID; HLA-DR ANTIGENS; HUMANS; KERATOCONJUNCTIVITIS SICCA; LISSAMINE GREEN DYES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; STAINING AND LABELING; TEARS; VISUAL ACUITY;

EID: 84886089049     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318299549c     Document Type: Article

References (56)

1. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589.
2. Sheppard JD. Guidelines for the treatment of chronic dry eye disease. Manag Care. 2003;12:20-25.
3. Altinors DD, Akça S, Akova YA, et al. Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol. 2006;141: 1016-1021.
4. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.
5. Uchino M, Schaumberg DA, Dogru M, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology. 2008;115:1982-1988.
6. Uchiyama E, Aronowicz JD, Butovich IA, et al. Increased evaporative rates in laboratory testing conditions simulating airplane cabin relative humidity: an important factor for dry eye syndrome. Eye Contact Lens. 2007;33:174-176.
7. Miljanović B, Trivedi KA, Dana MR, et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82:887-893.
8. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337-342.
9. Stern ME, Schaumburg CS, Dana R, et al. Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol. 2010;3:425-442.
10. Sheppard JD, Scoper SV, Samudre S. Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease. J Ocul Pharmacol Ther. 2011;27:23-27.
11. Rees D, Miles EA, Banerjee T, et al. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr. 2006;83:331-342.
12. Trebble TM, Wootton SA, Miles EA, et al. Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr. 2003;78:376-382.
13. Caughey GE, Mantzioris E, Gibson RA, et al. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr. 1996;63: 116-122.
14. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989;320: 265-271.
15. Lo CJ, Chiu KC, Fu M, et al. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res. 1999;82:216-221.
16. Novak TE, Babcock TA, Jho DH, et al. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol. 2003;284:L84-L89.
17. Chotikavanich S, de Paiva CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009;50:3203-3209.
18. De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci. 2007;48:2553-2560.
19. Pflugfelder SC. Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;152:900-909.e1.
20. Zhang X, Chen W, De Paiva CS, et al. Desiccating stress induces CD4+ T-cell-mediated Sjögren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-g. Am J Pathol. 2011;179:1807-1814.
21. Kelley DS, Taylor PC, Nelson GJ, et al. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids. 1999;34:317-324.
22. DeLuca P, Rossetti RG, Alavian C, et al. Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo. J Investig Med. 1999;47:246-250.
23. Wu D, Meydani M, Leka LS, et al. Effect of dietary supplementation with black currant seed oil on the immune response of healthy elderly subjects. Am J Clin Nutr. 1999;70:536-543.
24. Kapoor R, Huang YS. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Curr Pharm Biotechnol. 2006;7:531-534.
25. Hrelia S, Bordoni A, Celadon M, et al. Age-related changes in linoleate and alpha-linolenate desaturation by rat liver microsomes. Biochem Biophys Res Commun. 1989;163:348-355.
26. Barham JB, Edens MB, Fonteh AN, et al. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000;130:1925-1931.
27. Viau S, Leclère L, Buteau B, et al. Polyunsaturated fatty acids induce modification in the lipid composition and the prostaglandin production of the conjunctival epithelium cells. Graefes Arch Clin Exp Ophthalmol. 2012;250:211-222.
28. Calder PC, Zurier RB. Polyunsaturated fatty acids and rheumatoid arthritis. Curr Opin Clin Nutr Metab Care. 2001;4:115-121.
29. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885-897.
30. Aragona P, Bucolo C, Spinella R, et al. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. Invest Ophthalmol Vis Sci. 2005;46:4474-4479.
31. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003;22:97-101.
32. Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008;31:141-146;quiz 170.
33. Creuzot C, Passemard M, Viau S, et al. Improvement of dry eye symptoms with polyunsaturated fatty acids [in French]. J Fr Ophtalmol. 2006; 29:868-873.
34. Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol. 2011;89: e591-e597.
35. HHS-USDA. Dietary Guidelines for Americans. 7th ed. Washington, DC: U.S. Government Printing Office; 2010.
36. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease index. Arch Ophthalmol. 2000; 118:615-621.
37. de Paiva CS, Lindsey JL, Pflugfelder SC. Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology. 2003; 110:1102-1109.
38. Pflugfelder SC, De Paiva CS, Villarreal AL, et al. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea. 2008;27:64-69.
39. Pisella PJ, Brignole F, Debbasch C, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology. 2000;107:1841-1849.
40. Creuzot-Garcher C, Baudouin C, Labetoulle M, et al. Efficacy assessment of Nutrilarm, a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome [in French]. J Fr Ophtalmol. 2011;34:448-455.
41. Metcalf RG, James MJ, Gibson RA, et al. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr. 2007;85: 1222-1228.
42. Schaumburg CS, Siemasko KF, De Paiva CS, et al. Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol. 2011;187:3653-3662.
43. De Saint Jean M, Baudouin C, Di Nolfo M, et al. Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line. Exp Eye Res. 2004;78:257-274.
44. Stahl JL, Cook EB, Graziano FM, et al. Differential and cooperative effects of TNFalpha, IL-1beta, and IFNgamma on human conjunctival epithelial cell receptor expression and chemokine release. Invest Ophthalmol Vis Sci. 2003;44:2010-2015.
45. Huang JF, Yafawi R, Zhang M, et al. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease. Ophthalmology. 2012;119:e43-e50.
46. Allen SJ, Mott KR, Chentoufi AA, et al. CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infection. J Virol. 2011;85:9945-9955.
47. Chen YT, Li S, Nikulina K, et al. Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye. Mol Vis. 2009;15:563-576.
48. Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308:1024-1033.
49. Belch JJ, Hill A. Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr. 2000;71:352S-356S.
50. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum. 1990;33:810-820.
51. Belluzzi A, Boschi S, Brignola C, et al. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 2000;71:339S-342S.
52. Jamal GA, Carmichael H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet Med. 1990;7:319-323.
53. Schnappinger M, Sausenthaler S, Linseisen J, et al. Fish consumption, allergic sensitisation and allergic diseases in adults. Ann Nutr Metab. 2009;54:67-74.
54. Mark BJ, Beaty AD, Slavin RG. Are fish oil supplements safe in finned fish-allergic patients? Allergy Asthma Proc. 2008;29:528-529.
55. Tahvonen RL, Schwab US, Linderborg KM, et al. Black currant seed oil and fish oil supplements differ in their effects on fatty acid profiles of plasma lipids, and concentrations of serum total and lipoprotein lipids, plasma glucose and insulin. J Nutr Biochem. 2005;16: 353-359.
56. Fa-lin Z, Zhen-yu W, Yan H, et al. Efficacy of blackcurrant oil soft capsule, a Chinese herbal drug, in hyperlipidemia treatment. Phytother Res. 2010;24(suppl 2):S209-S213.